Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

Menu

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
My View
Tags:
BioPharmaceutical

Who's Watching The Watchmen This Time? The Mystery Of The New IRB Sting

This article was originally published in The Pink Sheet Daily

  • News

Executive Summary

Institutional review boards appear to be facing vigilante regulation as FDA warns that someone is submitting fictitious studies for review.

You may also be interested in...



IRBs Punked Again: FDA Sends Warning Letter To Essex IRB For Approving Fictitious Trial

In an operation highly reminiscent of a government sting three and a half years ago, "Dateline NBC" snares a for-profit IRB using a fictitious protocol.

IRBs Punked Again: FDA Sends Warning Letter To Essex IRB For Approving Fictitious Trial

In an operation highly reminiscent of a government sting three and a half years ago, "Dateline NBC" snares a for-profit IRB using a fictitious protocol.

IRB Quality Concerns Take Center Stage After FDA Clamps Down On Coast

Quality has moved up in importance as a criterion for selecting an institutional review board following an April 14 FDA warning letter to Coast IRB and the company's agreement to halt enrollment in clinical studies it monitors

Table

View full table

Topics

Tags:
BioPharmaceutical
Latest Headlines

Preterm Birth Patients Sought By US FDA As Meeting On Treatment Development Looms

US Supreme Court Seems Convinced Purdue Bankruptcy Plan Should Go Forward

US FDA’s START Program Might See Expanded Funding If Pilot Meets Speed Goals

Did Product Quality Decline While US FDA Inspectors Were Away?

See All
UsernamePublicRestriction

Register

PS071909

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By